Haleonの株価目標は上昇し、配当はほぼ倍増し、財務の健全性と成長を示しています。 Haleon's stock target rises, dividend nearly doubles, signaling financial health and growth.

ハレオン (Haleon) は,主要な消費者保健企業で,その株価目標が,ベレンバーグ銀行によって, GBX 457 にわずかに上昇し, "買い"の評価を維持しました. Haleon, a major consumer health company, saw its stock price target slightly rise to GBX 457 by Berenberg Bank, maintaining a 'buy' rating. 最新の四半期における同社のEPSはGBX1580で,アナリストは年度19.50を予測している. The company's EPS for the latest quarter was GBX 15.80, with analysts predicting 19.50 for the year. またハレオンは,当該配当額を1株あたり0.12ドルに増額した. Haleon also increased its dividend to $0.12 per share, up from $0.05, for shareholders of record on April 25, payable on June 5. この増加は,過去四半期に354億ドルの強い収入とともに, 金融の健康と成長の可能性を示しています. This increase, along with a strong revenue of $3.54 billion in the last quarter, indicates financial health and growth potential.